URGN vs VNQ
UroGen Pharma Ltd (URGN) versus VNQ (VNQ) — a side-by-side from cached financials, not a winner call.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
VNQ (VNQ) common stock.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
VNQ does not have a complete income-statement cache yet.
URGN currently screens at market cap $1.61B. VNQ currently screens at market cap $0.
Not investment advice. Open the URGN and VNQ stock pages for the full models.
Not investment advice.